04/28/2025
7:47 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 424B7 | |
04/28/2025
7:35 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
3:05 PM | Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
3:10 PM | Nicacio Leonardo Viana (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
10:17 AM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Zummo Jacqueline (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
11:58 AM | JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/05/2025
7:07 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
7:16 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:40 PM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
5:24 PM | CITADEL ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
10:23 AM | JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for TARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
5:31 AM | Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:30 AM | Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/23/2025
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:05 PM | Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:05 PM | Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:34 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:20 PM | Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:20 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:20 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:02 PM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Velan Capital Investment Management LP (Filed by)
| Form SC 13G | |
12/11/2024
3:19 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
6:30 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 424B5 | |
12/09/2024
3:17 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 424B5 | |
12/05/2024
7:45 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
5:01 AM | Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
11:19 AM | CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G/A | |
09/12/2024
7:20 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
6:11 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:16 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2024
3:05 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
6:56 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:00 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:45 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | BESHAR LUKE M (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | GARCEAU ROGER (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Huang Jane (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Levy Richard S (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
SARGEN GREGORY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Man I Turn to In Times Like This (Ad) A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.”
Tilson just released a new prediction that runs counter to what mainstream finance is telling you. Market chaos? Hear Tilson’s take now |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Solomon Michael Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Flannelly Barry P (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:01 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:48 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:57 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
11:15 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form EFFECT | |
05/02/2024
3:16 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/02/2024
7:05 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
7:10 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Buy TARA Stock Free TARA Stock Alerts